The Latest Breaking News from Med

The hits keep coming on Chicago Med, and another big loss may be on the way before the end of Season 8.

Many primary care practitioners are not adequately trained in pain management since learning about it is not required in medical school or during residency, a physician writes.

The Fed’s indication of continuing rate hikes and impending recession fears is likely to keep the stock market under pressure for a while. Therefore, investors looking for a stable income can scoop up quality dividend-paying stocks PepsiCo (PEP), Medifast (MED), and Genie Energy (GNE) and hold forever. Read on….

Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED).

Medifast Inc (NYSE:MED) has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase, National Association. Under the agreement, Medifast will repurchase an aggregate of $100 million of its common stock. The buyback equates to about 600,000 shares at the closing price on May 31, 2022, representing 5% of its outstanding stock.…

According to Benzinga Pro, during Q1, Medifast (NYSE:MED) earned $41.78 million, a 22.8% increase from the preceding quarter. Medifast also posted a total of $417.60 million in sales, a 10.52% increase since Q4.

Medifast (NYSE:MED) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Medifast beat estimated earnings by 0.56%, reporting an EPS of $3.59 versus an estimate of $3.57.

Medifast (NYSE:MED) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Medifast will report an earnings per share (EPS) of $3.56.

Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED).